Skip to main navigation Skip to search Skip to main content

Zanubrutinib in Bing Neel syndrome: efficacy and tolerability

  • Anne-Marie L. Becking*
  • , Johannes P. M. van de Mortel
  • , Oliver Tomkins
  • , Thijs W. H. Flinsenberg
  • , Nicole Japzon
  • , Marie José Kersten
  • , Jahanzaib Khwaja
  • , Saskia Kuipers
  • , Henriette Levenga
  • , Sean McKeague
  • , Stephen Opat
  • , Ross T. Salvaris
  • , Sherif Seif
  • , Sheeba K. Thomas
  • , Alexander F. J. E. Vrancken
  • , Shirley D’Sa
  • , Monique C. Minnema
  • , Josephine M. I. Vos
  • *Corresponding author for this work
  • Amsterdam UMC
  • Utrecht University
  • University Medical Center Utrecht
  • University College London Hospitals NHS Foundation Trust
  • Rijnstate Hospital
  • Admiraal de Ruyter Hospital
  • Groene Hart Hospital
  • Department of Internal Medicine
  • Peter Maccallum Cancer Centre
  • Department of Hematology
  • Monash University
  • University of Texas MD Anderson Cancer Center
  • University of Texas M.D. Anderson Cancer Center, Houston, United States

Research output: Contribution to journalComment/Letter to the editorAcademic

33 Downloads (Pure)
Original languageEnglish
Article numbere155
Pages (from-to)1260-1264
Number of pages5
JournalLeukemia
Volume39
Issue number5
Early online date2025
DOIs
Publication statusPublished - May 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this